The effects of green cardamom supplementation on blood pressure and endothelium function in type 2 diabetic patients:

Related Experiment Video

Updated: Dec 22, 2025

Extraction and Analysis of Taiwanese Green Propolis
06:50

Extraction and Analysis of Taiwanese Green Propolis

Published on: January 7, 2019

9.0K

Shohreh Ghazi Zahedi1, Fariba Koohdani2, Mostafa Qorbani3

  • 1Department of Community Nutrition.

Medicine
|May 3, 2020
PubMed

Insights

Green cardamom supplementation may improve blood pressure and markers of inflammation and endothelial function in type 2 diabetes patients. This 10-week study investigated cardamom

Area of Science:

  • Cardiovascular Health
  • Metabolic Disorders
  • Nutritional Science

Background:

  • Cardamom has known antioxidant and anti-inflammatory properties.
  • Limited research exists on cardamom's effects in type 2 diabetes patients.
  • Endothelial dysfunction is a concern in type 2 diabetes.

Purpose of the Study:

  • To evaluate the impact of 10-week green cardamom intake on blood pressure.
  • To assess changes in inflammatory and endothelial function biomarkers.
  • To explore potential mechanisms of action in type 2 diabetes mellitus (T2DM) patients.

Main Methods:

  • A 10-week randomized controlled trial involving 80 overweight/obese T2DM patients.
  • Participants received either 3g/day cardamom or a placebo.
  • Measurements included blood pressure, asymmetric dimethylarginine, nitric oxide, and various inflammatory/endothelial markers.

Main Results:

  • (Results not yet available as per abstract)
  • The study design allows for comprehensive analysis of cardamom's effects.
  • Data on blood pressure and biomarker changes will be collected at baseline and study end.

Conclusions:

  • (Conclusions not yet available as per abstract)
  • This study will provide novel insights into cardamom's therapeutic potential for T2DM.
  • Findings may inform dietary recommendations for managing T2DM.
Abstract

More Related Videos

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model05:58

Mouse Electroacupuncture Fixation Device Fabrication for Electroacupuncture Pretreatment in Diabetic Cardiomyopathy Mouse Model

Published on: April 18, 2025

495
Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug05:57

Author Spotlight: Exploring Huotan Jiedu Tongluo Decoction as an Antihypertensive Drug

Published on: May 17, 2024

1.1K

Related Concept Videos

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
4.2K
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
365
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...
473
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
618
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.5K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
289